Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Gai, Zhongtao  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Zhang H, Ma Y, Yan B, Yang X, Li Y, Guan J, Dong R, Liu Y, Gai Z. Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene. Stem Cell Res. 2019;40:101565.
Wang B, Yang L, Gao M, Zhang H, Liu Y, Gai Z. Establishment of a human induced pluripotent stem cell line(SDQLCHi059-A)from a patient with congenital disorder of glycosylation carrying heterozygous mutation in MPI gene. Stem Cell Res. 2024;77:103381.
Wang B, Yang L, Li Y, Gao M, Zhang H, Yang X, Guan J, Liu Y, Gai Z. Establishment of a human induced pluripotent stem cell line (SDQLCHi037-A) from a patient with Alagille syndrome carrying heterozygous mutation in JAG1 gene. Stem Cell Res. 2021;51:102162.
Yang X, Duan C, Zhang H, Li Y, Guan J, Wang D, Lv Y, Gai Z, Liu Y. Establishment of a non-integrate iPS cell line (SDQLCHi023-A) from a patient with Xq25 microduplication syndrome carrying a 1.3 Mb hemizygote duplication at chrXq25. Stem Cell Res. 2020;51:102147.
Zhang X, Li Z, Liu Y, Xin H, Gai Z. Establishment of a non-integrated iPSC (SDQLCHi066-A) line derived from Segawa syndrome patients harboring heterozygous mutations in the TH gene (p.G247S and p.D491H). Stem Cell Res. 2024;77:103392.
Xin H, Lv Y, Wei X, Song W, Li Z, Liu Y, Gai Z. Establishment of a non-integrated iPSC (SDQLCHi068-A) line derived from a patient with autosomal dominant immunodeficiency-14A carrying a heterozygous mutation (c.3061G>A) in PIK3CD gene. Stem Cell Res. 2024;77:103385.
Li Z, Liu C, Xin H, Yang Y, Wang Y, Niu S, Gao C, Gai Z, Liu Y. Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome. Stem Cell Res. 2022;66:102984.
G
Gao M, Li X, Lv Y, Yang X, Liu Y, Gai Z. Generation and characterization of an induced pluripotent stem cell (iPSC) line SDQLCHi063-A from peripheral blood mononuclear cells of a patient with Maturity-onset diabetes of the young type 2 carrying GCK exon 1 deletion. Stem Cell Res. 2024;77:103389.
Zhang H, Zhang H, Ma Y, Lv Y, Gai Z, Liu Y. Generation and characterization of an induced pluripotent stem cell line SDQLCHi018-A from a congenital myasthenic syndrome patient carrying compound heterozygote mutations in RAPSN gene. Stem Cell Res. 2021;51:102160.
Guan J, Li Z, Zhang H, Yang X, Ma Y, Li Y, Dong R, Gai Z, Liu Y. Generation of a Human iPSC line (SDQLCHi021-A) from a patient with methylmalonic acidemia cblC type carrying compound heterozygous mutations in MMAHC gene. Stem Cell Res. 2020;43:101709.
Wang Y, Yang X, Zhang H, Liu N, Liu Y, Gai Z, Liu Y, Lv Y. Generation of a transgene-free iPS cell line (SDQLCHi053-A) from a young girl carrying a heterozygous mutation (c.427C > T) in SYNGAP1 gene. Stem Cell Res. 2023;71:103132.
Zhang H, Ma Y, Song F, Yang X, Li Y, Guan J, Lv Y, Gao M, Ma J, Liu Y, et al. Generation of an induced pluripotent stem cell line (SDQLCHi003-a) from a patient with short rib-thoracic dysplasia syndrome type III carrying compound heterozygous mutations in DYNC2H1. Stem Cell Res. 2019;39:101505.
Yang X, Zhou T, Zhang H, Li Y, Dong R, Liu N, Pan G, Liu Y, Gai Z. Generation of an induced pluripotent stem cell line (SDQLCHi008-A) from a patient with ASD and DD carrying an 830 kb de novo deletion at chr7q11.22 including the exon 1 of AUTS2 gene. Stem Cell Res. 2019;40:101557.
Zhang H, Liu C, Ma Y, Lin L, Lv Y, Gao M, Gai Z, Liu Y. Generation of an induced pluripotent stem cell line SDQLCHi026-A from a hereditary tyrosinemia type I patient carrying compound heterozygote mutations in FAH gene. Stem Cell Res. 2021;53:102331.
Li Y, Zhang H, Guan J, Wang B, Zhang H, Liu Y, Gai Z. Generation of an iPSC line (SDQLCHi030-A) derived from PBMCs of a patient with Lesch-Nyhan syndrome caused by HPRT1 mutation. Stem Cell Res. 2023;74:103287.
Ma Y, Zhang H, Yang X, Li Y, Guan J, Zhang K, Huang Y, Pan G, Gai Z, Liu Y. Generation of two induced pluripotent stem cell lines from patients with unbalanced translocation (3;22). Stem Cell Res. 2019;40:101545.